- Home
- NURO vs QNTM Comparison
NURO vs QNTM Comparison
Compare NURO & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- QNTM
- Stock Information
- Founded
- NURO 1996
- QNTM 1998
- Country
- NURO United States
- QNTM Canada
- Employees
- NURO N/A
- QNTM N/A
- Industry
- NURO Medical/Dental Instruments
- QNTM
- Sector
- NURO Health Care
- QNTM
- Exchange
- NURO Nasdaq
- QNTM NYSE
- Market Cap
- NURO 7.6M
- QNTM 9.1M
- IPO Year
- NURO N/A
- QNTM N/A
- Fundamental
- Price
- NURO $3.86
- QNTM $3.48
- Analyst Decision
- NURO
- QNTM
- Analyst Count
- NURO 0
- QNTM 0
- Target Price
- NURO N/A
- QNTM N/A
- AVG Volume (30 Days)
- NURO 23.4K
- QNTM 97.9K
- Earning Date
- NURO 11-05-2024
- QNTM 12-31-2024
- Dividend Yield
- NURO N/A
- QNTM N/A
- EPS Growth
- NURO N/A
- QNTM N/A
- EPS
- NURO N/A
- QNTM N/A
- Revenue
- NURO $3,767,764.00
- QNTM N/A
- Revenue This Year
- NURO N/A
- QNTM N/A
- Revenue Next Year
- NURO N/A
- QNTM N/A
- P/E Ratio
- NURO N/A
- QNTM N/A
- Revenue Growth
- NURO N/A
- QNTM N/A
- 52 Week Low
- NURO $2.66
- QNTM $3.42
- 52 Week High
- NURO $4.73
- QNTM $70.85
- Technical
- Relative Strength Index (RSI)
- NURO 51.55
- QNTM 30.23
- Support Level
- NURO $3.63
- QNTM $4.03
- Resistance Level
- NURO $4.07
- QNTM $4.50
- Average True Range (ATR)
- NURO 0.24
- QNTM 0.55
- MACD
- NURO -0.03
- QNTM -0.06
- Stochastic Oscillator
- NURO 56.09
- QNTM 2.63
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.